Why the study?
What is the frequency of exposure to potentially interacting drugs among ambulatory patients receiving oral anticoagulants?
What is the frequency of exposure to potentially interacting drugs among ambulatory patients receiving oral anticoagulants?
A high proportion of ambulatory patients on oral anticoagulants are exposed to potentially interacting medications, strongly correlating with polypharmacy.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to screen polypharmacy patients on OAC for interactions; leaves open effects on clinical outcomes.
Computer-generated prescription drug purchase records for ambulatory patients receiving oral anticoagulants (OAC) were studied for concomitant use of other drugs which have been reported to induce clinically significant interactions. One third of 479 patients taking OAC were exposed to a potentially interacting drug at some time during this 6-month period. The percentage of patients with drug interaction exposure correlated directly with total drug use (p less than 0.0005). There were no significant differences when interaction exposure rates were compared in the cases of single : multiple pharmacy and single : multiple physician-patient groups. Warfarin was the most common anticoagulant (greater than 95%) and barbiturates the most common interacting drug.
No takes yet. Share an insight, caveat, or question.
Hull et al. (1978) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: